Fisher & Paykel Healthcare (FPH.AX) Earnings Analysis

Fisher & Paykel Healthcare (FPH.AX) has no confirmed upcoming earnings date. Last quarter (2026-05-26) it beat with EPS 0.3633 AUD vs 0.3487 AUD est (+4.2%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 49.88.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does FPH.AX next report earnings?

No confirmed upcoming earnings date is currently scheduled for FPH.AX. This page updates as the calendar is published.

FPH.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-260.3633 AUD0.3487 AUD+4.2%Beat
2026-05-250.358 AUD0.3568 AUD+0.3%Beat
2024-09-300.2352 AUD0.2452 AUD-4.1%Miss

Beat rate: 2/3 (67%) over reported quarters with consensus data.

FPH.AX valuation and analyst view

Trailing P/E49.88
Trailing EPS0.79821 AUD
Price / book11.07
Dividend yield1.53%
Market cap19.42B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Fisher & Paykel Healthcare (FPH.AX)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for FPH.AX. This page updates as the calendar is published.

Did FPH.AX beat earnings last quarter?

In its 2026-05-26 report, FPH.AX posted EPS of 0.3633 AUD versus a 0.3487 AUD estimate — a beat of 4.2%.

What is FPH.AX's earnings track record?

Over the last 3 reported quarters with consensus data, FPH.AX beat estimates 2 times (67%).

What is FPH.AX's current P/E ratio and EPS?

FPH.AX trades at a trailing P/E of 49.88 on trailing EPS of 0.7982119670296102 AUD.

What do analysts rate FPH.AX?

FPH.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.